Genentech Pursues Research to Challenge Proposed Pharma Reforms
Genentech is seeking research to bolster its position against potential pharmaceutical reforms in Washington, aiming to influence policy discussions.
Latest Medicine stories from Life.
Genentech is seeking research to bolster its position against potential pharmaceutical reforms in Washington, aiming to influence policy discussions.
Recent findings reveal significant issues with the release of drugs from nanoparticle carriers, raising concerns for the future of precision medicine.
The Department of Justice has ordered an executive from Elevance to testify regarding allegations of fraudulent billing related to Medicare Advantage.
Eli Lilly's investigational drug, known as 'triple-G', has demonstrated significant effects on blood sugar and weight in a late-stage diabetes trial.
In a move to address leadership vacancies, Kennedy has appointed Stephanie Haridopolos, a family medicine physician and senior HHS adviser, as interim surgeon general.
Researchers have identified a crucial enzyme in bioluminescent fungi, potentially leading to more effective medical tools that utilize light.
Goat’s rue, a wild plant known for its beauty, has played a significant role in the development of metformin, a key medication for diabetes and obesity, without the adverse effects.
At the STAT Breakthrough Summit West, 23andMe announced a partnership with HealthEx, enabling users to connect their DNA data with their medical records.
In a notable decision, Virginia's governor has vetoed legislation that sought to establish an advisory panel aimed at lowering prescription drug prices, impacting potential savings for residents.
Researchers at Florida State University have made significant strides in drug discovery by synthesizing new molecules from bacteria sourced from a Pacific Ocean sea sponge, which could aid in developing treatments for rare cancers.
A recent analysis indicates that most Canadian medical societies do not have adequate conflict-of-interest policies, with many existing policies being fragmented and limited in scope.
In a notable move, Maryland's State Affordability Board has established a price cap on Ozempic, joining nine other states exploring similar affordability measures for prescription drugs.
The Trump administration has announced a significant expansion of its drug discount platform, TrumpRx, adding 600 generic medications through partnerships with major online pharmacies.
Researchers at the University of Connecticut have developed a microneedle patch vaccine that could address significant challenges in agricultural vaccine distribution.
As the Ebola outbreak continues in the Democratic Republic of the Congo, experts are contemplating the testing of an unapproved vaccine, given the lack of approved options.
AstraZeneca has received FDA approval for its hypertension medication, marking a significant development in the biotech sector amid ongoing discussions about FDA leadership and other industry news.
The Supreme Court's decision could complicate ongoing lawsuits from pharmaceutical companies regarding drug price negotiations.
Two advocacy groups are urging the U.K. government to reconsider regulations tied to a U.S. pharma trade deal, threatening legal action if changes are not made.
Tracy Beth Høeg's resignation from the FDA's drug center follows the recent departure of Commissioner Marty Makary, highlighting a troubling leadership gap within the agency.
This editorial explores the federal government's Vaccine Injury Compensation Program and the Countermeasures Injury Compensation Program, highlighting their history and ongoing policy discussions.